| Synonyms: | |
| Status: | Approved (2003) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | M05BA06 |
| UNII: | UMD7G2653W |
| InChI Key | MPBVHIBUJCELCL-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C9H23NO7P2 |
| Molecular Weight | 319.23 |
| AlogP | 0.5 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 138.53 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 19.0 |
| Primary Target | |
|---|---|
| farnesyl diphosphate synthase |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | 20-1052 | - | 4-195 | - | |
|
Enzyme
|
- | 20-1052 | - | 4-195 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoporosis | 3 | D010024 | ClinicalTrials |
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
| Osteonecrosis | 3 | D010020 | ClinicalTrials |
| Hematologic Neoplasms | 3 | D019337 | ClinicalTrials |
| Bone Neoplasms | 3 | D001859 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Neoplasm Metastasis | 3 | D009362 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Osteoporosis, Postmenopausal | 3 | D015663 | ClinicalTrials |
| Abdominal Pain | 3 | D015746 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 114084-78-5 |
| ChEMBL | CHEMBL997 |
| DrugBank | DB00710 |
| DrugCentral | 1404 |
| EPA CompTox | DTXSID5048340 |
| FDA SRS | UMD7G2653W |
| Human Metabolome Database | HMDB0014848 |
| Guide to Pharmacology | 3059 |
| PDB | BFQ |
| PharmGKB | PA10270 |
| PubChem | 60852 |
| SureChEMBL | SCHEMBL9183 |
| ZINC | ZINC000001533877 |